Accelerated Phase CML
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients (NCT06453902) | Shenzhen TargetRx Co., Ltd. | 2024-07-15 |
Track Accelerated Phase CML automatically
Every clearance here is in the API, with alerts when new ones post.